Danziger & De Llano
1-800-692-8608
We're standing by to help.
For mesothelioma patients and loved ones, we provide free resources, education, support and hope.
New Zealand Trade Unions Call For Asbestos Ban

New Zealand Trade Unions Call For Asbestos Ban

As is true all around the world, New Zealand sees its share of deaths from mesothelioma and other asbestos-related diseases. The country’s physicians are currently recording approximately 170 deaths every year that are being attributed to the toxic substance, and it is anticipated that the number will rise to over 300 as more workers who…

Read More 
Number of Asbestos-Related Lung Cancer Cases on the Rise

Number of Asbestos-Related Lung Cancer Cases on the Rise

Asbestos has long-been known to be the cause of mesothelioma, an always fatal form of cancer that is diagnosed in roughly 2,500 to 3,500 Americans every year.  The mineral, which has long been used because of its characteristic strength and heat and flame resistance, was largely banned for use in the United States because of…

Read More 
Pleural Mesothelioma Patients Can Utilize Less Invasive Biopsy Procedure

Pleural Mesothelioma Patients Can Utilize Less Invasive Biopsy Procedure

Mesothelioma is a rare and always fatal form of cancer that can be difficult to diagnose. The condition is extremely rare and is only diagnosed in approximately 3,500 patients a year. One of the difficulties in diagnosing the disease is that one of the only definitive diagnostic tools is a surgical biopsy that may be…

Read More 
Italian Team Finds Success with New Compound

Italian Team Finds Success with New Compound

A team of researchers from the University of Padua and the Instituto Oncologico Veneto in Padua has reported having found that by combining a specific human protein with the chemotherapy drugs that are frequently utilized in the treatment of mesothelioma, they were able to provide a better result for the patients being treated. The compound…

Read More 
Korean Researchers Combine Leukemia Drug with Red Wine Compound

Korean Researchers Combine Leukemia Drug with Red Wine Compound

The red wine compound resveratrol has been a subject of much interest in the medical and scientific community. Some have thought it might have benefits for those suffering from heart conditions while others have focused on its potential for fighting cancer. Now the Korean researchers who first called the world’s attention to the compound’s benefits…

Read More 
Women’s Mesothelioma Survival Rate Found to be Much Higher Than Men’s

Women’s Mesothelioma Survival Rate Found to be Much Higher Than Men’s

A comprehensive study of mesothelioma in America has just been completed by researchers from the North Shore/Long Island Jewish Health System-Hofstra School of Medicine and Mount Sinai Health System in New York. The study involved more than 14,000 mesothelioma patients whose records had been compiled in the national Surveillance, Epidemiology and End Results (SEER) database…

Read More 
Mesothelioma Organization Establishes Innovative Fundraising Resource

Mesothelioma Organization Establishes Innovative Fundraising Resource

The Mesothelioma Applied Research Foundation, a national organization organized with the mission of funding mesothelioma research, helping mesothelioma patients, and advocating on behalf or mesothelioma research funding, has announced the creation of their new “Giving Circles” fundraising program. The group, which is also known as the Meso Foundation, has long been known as one of…

Read More 
Law for Breakthrough Drugs Providing Greater Progress

Law for Breakthrough Drugs Providing Greater Progress

The Advancing Breakthrough Therapies for Patients Act is a bill that was passed in July of 2012 by both the House of Representatives and the Senate and signed into law. Originally sponsored in the Senate by Senators Bennet (D-CO), Hatch (R-UT) and Burr (R-NC) and then pushed through the house by Congresswoman DeGette (D-CO) and…

Read More 
Research Reveals Platinum Drug Provides Superior Result in HIPEC Treatment

Research Reveals Platinum Drug Provides Superior Result in HIPEC Treatment

The most recent edition of the journal The American Surgeon contains the result of a study recently conducted by surgeons at Creighton University Medical Center in Omaha, Nebraska.  The surgeons were investigating whether there was a difference in the outcomes between mesothelioma patients who had received two different types of chemotherapy following an innovative surgery…

Read More 
Verastem Releases Results of Recent Study

Verastem Releases Results of Recent Study

Verastem, Inc., a drug company specializing in the development of medications to treat cancer by targeting and killing cancer stem cells, has just published a research paper titled “Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship.” The paper was published in the most recent edition of the journal Science Translational Medicine, and reveals…

Read More 
 

WE SPONSOR

American Cancer Society
MD Anderson Cancer Center
Methodist Hospital System
Make a Wish Foundation